XML 42 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)
6 Months Ended
Jul. 31, 2014
Jul. 31, 2013
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net earnings $ 249,729,000 $ 190,358,000
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Depreciation and amortization 97,214,000 86,323,000
Amortization of gain on sale-leasebacks (4,744,000) (4,733,000)
Excess tax benefits from share-based payment arrangements (12,504,000) (10,832,000)
Provision for inventories 14,741,000 17,421,000
Deferred income taxes 19,569,000 (8,343,000)
Provision for pension/postretirement benefits 19,655,000 24,505,000
Share-based compensation expense 13,398,000 15,309,000
Changes in assets and liabilities:    
Accounts receivable (200,000) 6,673,000
Inventories (213,332,000) (143,437,000)
Prepaid expenses and other current assets (23,257,000) (26,505,000)
Accounts payable and accrued liabilities (19,504,000) (22,857,000)
Income taxes payable 28,263,000 20,196,000
Merchandise and other customer credits (5,125,000) 2,018,000
Other, net (11,107,000) (26,016,000)
Net cash provided by operating activities 152,796,000 120,080,000
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchases of marketable securities and short-term investments (698,000) (616,000)
Proceeds from sales of marketable securities and short-term investments 21,729,000 0
Capital expenditures (91,126,000) (86,686,000)
Notes receivable funded 0 (3,050,000)
Proceeds from notes receivable 7,277,000 484,000
Net cash used in investing activities (62,818,000) (89,868,000)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from credit facility borrowings, net 13,966,000 3,244,000
Other proceeds from credit facility borrowings 12,067,000 82,643,000
Other repayments of credit facility borrowings (964,000) (68,100,000)
Repurchase of Common Stock (16,402,000) 0
Proceeds from exercised stock options 35,305,000 15,505,000
Excess tax benefits from share-based payment arrangements 12,504,000 10,832,000
Cash dividends on Common Stock (92,849,000) (83,209,000)
Distribution to non-controlling interest (1,910,000) 0
Financing fees (97,000) (893,000)
Net cash used in financing activities (38,380,000) (39,978,000)
Effect of exchange rate changes on cash and cash equivalents 866,000 (5,408,000)
Net increase/(decrease) in cash and cash equivalents 52,464,000 (15,174,000)
Cash and cash equivalents at beginning of year 345,778,000 504,838,000
Cash and cash equivalents at end of six months $ 398,242,000 $ 489,664,000